#2784 Exploring the role of mitochondrial genomic variants and haplogroups in clinical phenotypes of polycystic kidney disease
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background and Aims Polycystic kidney disease (PKD) is characterized by cyst development and kidney enlargement, inducing progressive kidney failure. Cystic cells appear to shift towards a metabolic state resembling tumours, but the mechanism is unclear. Mitochondrial DNA (mtDNA) variants can be pathogenic, causing multi-system disorders that often involve the kidney; these are largely heteroplasmic, or occur in only some mitochondria in the body. mtDNA variants and mitochondrial abnormalities have been identified in cysts from PKD patients. Additionally, mtDNA haplogroups have been associated with clinical outcomes in other kidney diseases. Collectively, this evidence suggests a role of mitochondria in PKD phenotypes. Here, we present the initial investigation of the mitochondrial genome in an Irish PKD cohort. Methods Exome sequencing with a mtDNA spike-in was conducted on 303 PKD patients from the Irish Kidney Gene Project. After filtering for >80× mtDNA coverage, 281 samples remained for analysis. GATK Mutect2 on mitochondrial mode was used for mitochondrial variant calling, and all variants with PASS filter were kept. Variants within homopolymeric tracts were excluded. Remaining variants were annotated with MseqDR, VEP, and MitImpact. Homoplasmic variants were identified with variant allele frequency >0.95 and used for determining haplogroups with Haplogrep3. Genotyping data was available for 264/281 patients. These 264 PKD patients were projected onto an Irish ancestry reference dataset of >2000 individuals using PCA to generate principal components of ancestry. Initial regression analyses were conducted using a Cox proportional hazards model in R to test for associations between mitochondrial haplogroup and age at kidney failure, correcting for sex, diagnostic variant, and ancestry. Statistical significance was determined from Bonferroni-corrected p-value <0.05 (0.05/10 = 0.005). Results 687 mtDNA variants were found across the 281 PKD patients, with 163 found as heteroplasmic and 639 found as homoplasmic. 99 individuals had at least one heteroplasmic variant. ACMG classification is underway for determining pathogenicity of the heteroplasmic variants. Mitochondrial haplogroups were assigned to 276/281 individuals, with 10 distinct haplogroups occurring in the cohort. The haplogroup distribution aligns with a prior Irish population study, confirming our cohort represents what is expected of an Irish population. 92 individuals had all data required to run the regression analysis. Initial regression analyses suggest that mitochondrial haplogroups I and T decrease kidney survival 15 years (adjusted-P = 0.009) and 19 years (adjusted-P = 0.006), respectively. However, further testing is required to confirm this signal. Conclusions Mitochondrial variation even within a small Irish PKD cohort is quite diverse. Heteroplasmic variants commonly occurred in our cohort, but these must be fully investigated for pathogenicity. We have built upon previous mitochondrial haplogroup association studies by incorporating an ancestry covariate to clarify the contributions of mitochondrial haplogroups to PKD clinical phenotypes.
Institutions: Royal College of Surgeons in Ireland, Beaumont Hospital
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W4415426537
